LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: A Modified Bicanalicular Crawford Placement Method for Congenital Nasolacrimal Duct Obstruction: Reducing Need for Operative Room Removal.

    Thompson, John P / Pharo, Austin M / Ingram, Ellen E / Bozner, Elizabeth M / Avdic, Armin / Ellis, George S

    Ophthalmic plastic and reconstructive surgery

    2023  Volume 39, Issue 6, Page(s) 628–631

    Abstract: Purpose: This study introduces a method for Crawford bicanalicular stent placement for congenital nasolacrimal duct obstruction by looping the ends to themselves which are tied together with dissolvable sutures to ease in-office removal.: Methods: ... ...

    Abstract Purpose: This study introduces a method for Crawford bicanalicular stent placement for congenital nasolacrimal duct obstruction by looping the ends to themselves which are tied together with dissolvable sutures to ease in-office removal.
    Methods: This is a single institution, retrospective study that evaluates outcomes of patients aged 5 years and under who underwent bicanalicular stenting for congenital nasolacrimal duct obstruction by a single surgeon (G.S.E.) between 2004 and 2020. Only primary surgeries were included in the analysis. Stenting could be accompanied by balloon dilatation and/or turbinate infracture. Age, sex, follow-up time, complications, type of intervention, extrusion, recurrence, and operative room removal were recorded.
    Results: This study included 56 eyes from 54 patients with a mean age of 19.0 ± 9.5 months (range, 8-50 months). There was a 30.3% extrusion rate, a 5.4% rate of recurrence of disease, and a 3.6% rate of operative room removal. The average follow-up time was 25.1 ± 39.8 months (range, 1-132 months). For patients with or without extrusion, there were no significant differences between age, sex, laterality, type of intervention, follow-up time, or rate of recurrence. Each eye that had recurrence (3 total) or needed operative room removal (2 total) underwent only bicanalicular stenting without accompanying procedures, although the difference in rates between procedures was also not statistically significant.
    Conclusions: This method had a low recurrence and operative room removal rate, with similar extrusion and complication rates to other bicanalicular stent and intubation methods for the treatment of congenital nasolacrimal duct obstruction.
    MeSH term(s) Humans ; Infant ; Child, Preschool ; Lacrimal Duct Obstruction/etiology ; Nasolacrimal Duct/surgery ; Nasolacrimal Duct/abnormalities ; Retrospective Studies ; Dacryocystorhinostomy/methods ; Intubation/methods ; Eye Abnormalities/etiology ; Treatment Outcome
    Language English
    Publishing date 2023-07-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 632830-1
    ISSN 1537-2677 ; 0740-9303
    ISSN (online) 1537-2677
    ISSN 0740-9303
    DOI 10.1097/IOP.0000000000002460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.

    Ingram, Ellen E / Bocklud, Brooke E / Corley, Sarah C / Granier, Mallory A / Neuchat, Elisa E / Ahmadzadeh, Shahab / Shekoohi, Sahar / Kaye, Alan D

    Current pain and headache reports

    2023  Volume 27, Issue 10, Page(s) 497–502

    Abstract: Purpose of review: Although the association between CGRP and migraine disease is well-known and studied, therapies can target other pathways to minimize migraine symptoms. It is important to understand the role of these medications as options for ... ...

    Abstract Purpose of review: Although the association between CGRP and migraine disease is well-known and studied, therapies can target other pathways to minimize migraine symptoms. It is important to understand the role of these medications as options for migraine treatment and the varied mechanisms by which symptoms can be addressed. In the present investigation, the role of non-CGRP antagonist/non-triptan options for migraine disease therapy is reviewed, including NSAIDs, ß-blockers, calcium channel blockers, antidepressants, and antiepileptics. Pharmacologic therapies for both acute symptoms and prophylaxis are evaluated, and their adverse effects are compared.
    Recent findings: At present, the Food and Drug Association has approved the beta-blockers propranolol and timolol and the anti-epileptic drugs topiramate and divalproex sodium for migraine prevention. Clinicians have other options for evidence-based treatment of episodic migraine attacks. Treatment decisions should consider contraindications, the effectiveness of alternatives, and potential side effects. NSAIDs are effective for the acute treatment of migraine exacerbations with caution for adverse effects such as gastrointestinal upset and renal symptoms. Beta-blockers are effective for migraine attack prophylaxis but are associated with dizziness and fatigue and are contraindicated in patients with certain co-morbidities, including asthma, congestive heart failure, and abnormal cardiac rhythms. Calcium channel blockers do not show enough evidence to be recommended as migraine attack prophylactic therapy. The anti-epileptic drugs topiramate and divalproex sodium and antidepressants venlafaxine and amitriptyline are effective for migraine exacerbation prophylaxis but have associated side effects. The decision for pharmacologic management should ultimately be made following consideration of risk vs. benefit and discussion between patient and physician.
    MeSH term(s) Humans ; Topiramate/therapeutic use ; Valproic Acid/therapeutic use ; Tryptamines ; Migraine Disorders/drug therapy ; Migraine Disorders/prevention & control ; Propranolol/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Antidepressive Agents/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Serotonin 5-HT1 Receptor Agonists ; Drug-Related Side Effects and Adverse Reactions
    Chemical Substances Topiramate (0H73WJJ391) ; Valproic Acid (614OI1Z5WI) ; Tryptamines ; Propranolol (9Y8NXQ24VQ) ; Calcium Channel Blockers ; Antidepressive Agents ; Anti-Inflammatory Agents, Non-Steroidal ; Serotonin 5-HT1 Receptor Agonists
    Language English
    Publishing date 2023-08-16
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2055062-5
    ISSN 1534-3081 ; 1531-3433
    ISSN (online) 1534-3081
    ISSN 1531-3433
    DOI 10.1007/s11916-023-01151-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Financial management and perioperative leadership in the ambulatory setting journal title: Best practice in clinical research.

    Abdullahi, Adamu / Roberts, Timothy Dean / Daniel, Charles P / Aucoin, Alise J / Ingram, Ellen E / Corley, Sarah C / Cornett, Elyse M / Kaye, Alan D

    Best practice & research. Clinical anaesthesiology

    2022  Volume 36, Issue 2, Page(s) 311–322

    Abstract: A large portion of US healthcare is ambulatory. Strong leadership is vital for the safety and efficiency of perioperative patients in this setting. Good leaders communicate respectfully and openly and ensure effective systems in the delivery of high- ... ...

    Abstract A large portion of US healthcare is ambulatory. Strong leadership is vital for the safety and efficiency of perioperative patients in this setting. Good leaders communicate respectfully and openly and ensure effective systems in the delivery of high-level healthcare. In general, to promote patient safety and treatment efficacy, ambulatory care leaders must improve communication. Effective administration is unattainable without leadership and communication in an operating room. When considering outpatient perioperative therapy, it is equally crucial to consider medical costs. Given the unsustainable rate of healthcare spending growth, all attempts to improve our present systems are necessary. Ambulatory care facilities must utilize data regarding resource consumption to be financially viable related to escalating expenses. The present review describes perioperative and financial leadership in the ambulatory setting, effective systems, and relevant clinical strategies.
    MeSH term(s) Ambulatory Care ; Ambulatory Care Facilities ; Financial Management ; Humans ; Leadership ; Operating Rooms
    Language English
    Publishing date 2022-08-13
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2051316-1
    ISSN 1878-1608 ; 1753-3740 ; 1521-6896
    ISSN (online) 1878-1608
    ISSN 1753-3740 ; 1521-6896
    DOI 10.1016/j.bpa.2022.08.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top